Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers

Thalidomide, which inhibits angiogenesis in certain tumor types, reduced extravasation of a macromolecular contrast medium (MMCM) in a human breast cancer model as assayed by MMCM-enhanced dynamic magnetic resonance imaging (MRI) and fluorescence microscopy in the same tumors. After a 1-week, three-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Radiol
Autors principals: Cyran, Clemens C., Sennino, Barbara, Chaopathomkul, Bundit, Fu, Yanjun, Rogut, Victor S., Shames, David M., Wendland, Michael F., McDonald, Donald M., Brasch, Robert C.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685658/
https://ncbi.nlm.nih.gov/pubmed/18665367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-008-1111-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars